Author: admin

Urinalysis Market Projected to Surpass USD 8.97 Billion by 2031, Witnessing 9.70% CAGR Growth

Global Urinalysis Market size was valued at USD 3.9 billion in 2022 and is poised to grow from USD 4.28 billion in 2023 to USD 8.97 billion by 2031, growing at a CAGR of 9.70% during the forecast period (2024-2031).

Global Urinalysis Market size was valued at USD 4.28 billion in 2023 to USD 8.97 billion by 2031, growing at a CAGR of 9.70% during the forecast period (2024-2031).

The Urinalysis Market is driven by rise in the prevalence of diseases such as renal, diabetes, and urinary tract infections (UTIs). For instance, in a National Diabetes Statistics Report by 2020, diabetes presently exists in about 34.1 million individuals in the US aged 18 years and above. About one-third of these diabetics have kidney-related comorbidities related to blood pressure and blood sugar. Urinalysis is a noninvasive diagnostic technique that informs a physician about kidney dysfunction. Therefore, the rising incidence of renal diseases is expected to drive demand for related urinalysis goods, which in turn shall further fuel market growth. Moreover, the increasing aging population, government-sponsored awareness campaigns, and related technological advancements in urinalysis are expected to drive growth within the market during the forecast period. For instance, in July 2018, ARKRAY, Inc. and Beckman Coulter, Inc. collaborated to introduce the iQ Urinalysis Workcell-a fully automated urine analyzer.

 

Get a Free Sample Research Report:https://www.skyquestt.com/sample-request/urinalysis-marketUrinalysis Market

 

Segmental Analysis

Global Urinalysis Market is segmented by Product, Test Type, Application, End User, and region. 

Based on Product, the market is segmented into Consumables, and Instruments. 

Based on Test Type, the market is segmented into Pregnancy & Fertility Tests, Biochemical Tests, and Sediment Urinalysis.

Based on Application, the market is segmented into Disease Screening, and Pregnancy & Fertility Testing. 

Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, and Research Laboratories & Institutes. 

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

 

Integration of Point-of-Care Diagnostics in Modern Healthcare

This is highlighted in the rising usage of point-of-care urine testing in scenarios characterized by increasing demands for rapid, point-of-care diagnostic solutions. There is technology that can enhance the ability of healthcare workers to make rapid judgments in various situations such as now results can be received instantly. Tests like this can enable early diagnosis and intervention that would greatly improve the patient’s outcome by delivering relevant information at the time of treatment. Point-of-care urinalysis helps expedite healthcare delivery by eliminating any need for laboratory processing and minimization of waiting times. This kind of testing is predicted to be integrated into more hospitals as there is a growing emphasis on efficiency and patient-centered care.

Within the last year, some of the most notable acquisitions have involved Danaher buying Beckman Coulter, a major supplier of laboratory instruments and consumables, while Abbott acquired Alere, the largest point-of-care diagnostics provider.

 

Ask for Customization:https://www.skyquestt.com/speak-with-analyst/urinalysis-market

 

This report covers following key players:

  • Siemens Healthineers AG  (Germany) 
  • F. Hoffmann-La Roche Ltd. (Switzerland) 
  • Cardinal Health (US) 
  • Danaher (US) 
  • Abbott (US) 
  • Sysmex Corporation (Japan) 
  • Thermo Fisher Scientific (US) 
  • QuidelOrtho Corporation (US) 
  • Becton, Dickinson and Company (US) 
  • Bio-Rad Laboratories, Inc. (US) 
  • EKF Diagnostics Holdings PLC (UK) 
  • Arkray, Inc. (Japan) 
  • ACON Laboratories, Inc. (US) 
  • 77 Elektronika Kft. (Hungary) 
  • URIT Medical Electronic Co., Ltd. (China) 
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China) 
  • Dirui Industrial Co., Ltd. (China) 
  • BIOBASE Group (China) 
  • Erba Mannheim (Germany) 
  • Alphatec Scientific E.I.R.L. (Peru) 
  • Teco Diagnostics (US) 
  • Analyticon Biotechnologies GmbH (Germany) 
  • Bioway Biological Technology Co., Ltd. (China)
  • High Technology, Inc. (US) 
  • Agappe Diagnostics Ltd (India) 
  • Toyobo Co., Ltd. (Japan) 
  • DIALAB GmbH (Austria) 
  • Quantimetrix (US) 
  • Biocare Corporation (Taiwan) 
  • Randox Laboratories Ltd. (UK) 
  • PZ Cormay S.A. (Poland) 
  • YD Diagnostics (South Korea) 
  • Contec Medical Systems Co., Ltd. (China) 
  • Biopanda Reagents Ltd. (UK)

 

Strategic Acquisitions and Technological Advances Driving Growth in Diagnostics

The key market players have adopted a strategy of growth, where growth includes the introduction of technological innovations, campaigns for introducing the products, acquisitions, and new product launches. In the UK, KDx Diagnostics, Inc. and Lister Hospital brought forward the URO17 non-invasive urine test in December 2021. This test focuses on the diagnosis of bladder cancer. It is non-invasive and allows the user to identify bladder cancer easily. With this introduction, its market position was developed. In addition, in 2022, it introduced the urine chemistry analyzer. This is a laboratory equipment that can be employed to measure many elements from the urine. They comprise glucose, protein, electrolytes among others.

Latest Technological Advances and Product Launches

Companies within the urinalysis market continually improve their offerings to enhance the detection and diagnostic capabilities of drugs and test faster. They are working hard towards developing and delivering the latest urinalysis products to keep pace with the ever-growing demand for diagnostic testing in medical facilities. These market leaders in the urinalysis market remain focused on R&D in a quest to introduce the latest products in the market and maintain their front runners’ position in this competition.

  • In September 2022, Sysmex Corporation released the UF-1500 Fully Automated Urine Particle Analyzer (UF-1500). It tests urine sediment.
  • In June 2022, at-home pregnancy test kit PregaScreen launched by Mylab Discovery Solutions and hence a woman can check whether she is pregnant on her own. The company is going to enter the female health market through this test kit.

 

 

View report summary and Table of Contents (TOC):  https://www.skyquestt.com/report/urinalysis-market

 

 

This report covers following segments:

A. Product

Consumables

Instruments

 

B. Test Type

Pregnancy & Fertility Tests

Biochemical Tests

 

C. Application

Disease Screening

Pregnancy & Fertility Testing

 

The Urinalysis Market is growing due to the increased frequency of chronic diseases, aging populations, and increased occurrences of kidney and urinary tract infections. Urinalysis is one of the essential diagnostic procedures for most medical professionals; it often helps in early detection of the disease and its management. Advances in technology and analytical techniques have significantly enhanced the accuracy and reliability of urinalysis. Replacing the conventional manual methods are automated and point-of-care technologies which yield immediate and reliable results.

 

Visit Our Website: https://www.skyquestt.com/

Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email: Send Email
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/urinalysis-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Urinalysis Market Projected to Surpass USD 8.97 Billion by 2031, Witnessing 9.70% CAGR Growth

The UAE Construction Equipment Market Sales is Set to Hit 28.5 Thousand Units by 2029, with Revenue Soaring by $1.27 Billion in the Next 6 Years – Arizton

“The UAE Construction Equipment Market Research Report by Arizton”

     

According to Arizton’s latest research report, the UAE construction equipment market is growing at a CAGR of 5.70% during 2023-2029.

 

Looking for More Information? Click: https://www.arizton.com/market-reports/uae-construction-equipment-market

  

Report Scope:      

Market Size – Volume (2029): 28.5 Thousand Units  

Market Size – Volume (2023): 20.4 Thousand Units  

CAGR (2023-2029): 5.70%    

Market Size – Revenue (2029): $1.27 Billion   

Historic Year: 2020-2022         

Base Year: 2023         

Forecast Year: 2024-2029     

 

The UAE construction equipment market is experiencing unprecedented growth, driven by the country’s aggressive investments in renewable energy and infrastructure development. With the UAE’s commitment to achieving net-zero emissions by 2050, significant funding flows into renewable energy projects are spurring demand for advanced construction machinery. The surge in projects related to energy storage, solar farms, and wind power installations has created a booming market for construction equipment, including excavators, cranes, and specialized machinery for site preparation and infrastructure.

 

The UAE Surge in Renewable Energy Funding Fuels Boom in the Construction Equipment Market

The UAE burgeoning renewable energy sector is not only advancing the country’s ambitious net-zero emissions goals by 2050 but is also driving a significant boom in the construction equipment market. Recent developments in the sector highlight the interconnected growth between renewable energy investments and construction equipment demand.

In the first half of 2024 alone, UAE energy startups secured a record $30 million in funding, surpassing the total $24 million raised throughout 2023. This surge in investment is particularly concentrated in energy storage and battery technologies, which received 33.3% of the funding, followed by solar energy firms with 25%. This financial momentum reflects a broader push towards renewable energy projects and infrastructure, which directly impacts the construction equipment sector.

The rapid expansion of renewable energy initiatives is driving a surge in demand for construction equipment. As the UAE undertakes more large-scale projects to build and upgrade energy storage facilities, solar farms, and other renewable energy infrastructure, the need for advanced construction machinery and equipment is escalating. This includes specialized equipment for site preparation, installation, and maintenance of renewable energy systems.

In addition to startup funding, significant moves by established entities are further fueling growth. In July 2024, Masdar, a leading UAE-based clean energy developer, issued a $1 billion green bond to fund new renewable energy projects. The bond’s overwhelming success, being 4.6 times oversubscribed, signals robust financial backing for upcoming projects. This influx of capital is expected to lead to increased construction activities, further boosting the demand for construction equipment.

Moreover, in August 2024, Emirates Water and Electricity Company (EWEC) introduced Clean Energy Certificates (CECs) for wind power, complementing existing solar and nuclear energy certificates. This expansion into wind energy requires new infrastructure, including wind farms and associated facilities, which will necessitate a range of construction equipment.

The combination of increased funding for renewable energy startups, major green bond issuances, and the introduction of new clean energy initiatives is creating a thriving environment for the construction equipment market in the UAE. As the country advances its renewable energy projects, the demand for construction machinery will continue its upward trajectory, driving growth and innovation within the sector.

 

Market Trends & Drivers

UAE’s National Hydrogen Strategy to Increase the Demand for Green Fuel-Integrated Construction Equipment

The country approved its National Hydrogen Strategy in Nov 2023, targeting the annual production of 15 million tonnes of green hydrogen by 2050. The UAE’s National Hydrogen Strategy aims to position the country as a global leader in hydrogen production and export, aligning with its sustainability goals.

The strategy focuses on developing a hydrogen economy, which could drive demand for hydrogen fuel construction equipment. As the UAE invests in green energy and infrastructure, construction equipment powered by hydrogen fuel may increase demand, particularly in projects supporting the country’s environmental and energy transition goals.

Growing Demand for Cranes in the Country in Response to Various LNG Projects

There is growing demand for LNG gas production projects in the UAE market. The demand for gas in the global market is expected to increase by 14% by 2030. Therefore, in 2024, Abu Dhabi National Oil Company (ADNOC) announced plans to expand the UAE LNG capacity to 126 million tons per year, increasing from 77 million tons by 2027. 

Additionally, in July 2024, Shell Overseas Holdings Limited agreed to invest in ADNOC’s Ruwais LNG project, taking a 10% stake. The project includes two LNG liquefaction trains with a combined capacity of 9.6 million metric tonnes per annum (MMtpa).

 

Book the Free Sample Now: https://www.arizton.com/market-reports/uae-construction-equipment-market

 

Key Vendors

  • Caterpillar
  • Komatsu
  • Volvo Construction Equipment
  • Hitachi Construction Machinery
  • Liebherr
  • SANY
  • Xuzhou Construction Machinery Group Co. Ltd. (XCMG)
  • JCB
  • Kobelco
  • Zoomlion Heavy Industry Science & Technology Co., Ltd.
  • CNH Industrial
  • HD Hyundai Construction Equipment
  • LiuGong
  • DEVELON
  • Tadano
  • Terex Corporation
  • SDLG
  • Manitou
  • MERLO S.p.A.
  • Yanmar
  • Fushun Yongmao Construction Machinery Co., Ltd.
  • Bomag
  • ElectroMech
  • KATO WORKS CO., LTD.
  • AUSA
  • Wacker Neuson
  • The Manitowoc Company, Inc.
  • JLG
  • AMMANN
  • Toyota Material Handling
  • Haulotte

 

Distributor Profiles

  • Abdulla Saeedi General Trading LLC
  • Anwar Al Quds Machinery
  • Kanoo Machinery
  • Al-Futtaim Auto & Machinery Company (FAMCO)
  • AL Mahroos
  • East And West Trading Est.
  • AL Waha Cranes
  • AL Marwan
  • Galadari Trucks & Heavy Equipments

 

Market Segmentation

Type

  • Earthmoving Equipment
  • Excavator
  • Backhoe Loaders
  • Wheeled Loaders
  • Other Earthmoving Equipment (Other loaders, Bulldozers, Trenchers, Motor Graders)
  • Road Construction Equipment
  • Road Rollers
  • Asphalt Pavers
  • Material Handling Equipment
  • Crane
  • Forklift & Telescopic Handlers
  • Aerial Platforms (Articulated Boom Lifts, Telescopic Boom lifts, Scissor lifts)
  • Other Construction Equipment
  • Dumper
  • Tipper
  • Concrete Mixer
  • Concrete Pump Truck

 

End Users

  • Construction
  • Mining
  • Manufacturing
  • Others (Power Generation, Utilities Municipal Corporations, Oil & Gas, Cargo Handling, Power Generation Plants, Waste Management)

 

In a nutshell, the Arizton Advisory & Intelligence market research report provides valuable market insights for industry stakeholders, investors, researchers, consultants, and business strategists aiming to gain a thorough understanding of the UAE construction equipment market. Request for Free Sample to get a glance at the report now: https://www.arizton.com/market-reports/uae-construction-equipment-market

 

What Key Findings Will Our Research Analysis Reveal?    

How big is the UAE construction equipment market?

What is the growth rate of the UAE construction equipment market?

Who are the key players in the UAE construction equipment market?

What are the trends in the UAE construction equipment market?

Which are the major distributor companies in the UAE construction equipment market?

    

Looking for Customization According to Your Business Requirement? https://www.arizton.com/customize-report/4488

 

Other Related Reports that Might be of Your Business Requirement    

 

GCC Construction Equipment Market – Strategic Assessment & Forecast 2024-2029

https://www.arizton.com/market-reports/gcc-construction-equipment-market

Saudi Arabia Construction Equipment Market – Strategic Assessment & Forecast 2024-2029[JS1] 

https://www.arizton.com/market-reports/saudi-arabia-construction-equipment-market

 

Why Arizton?                                               

100% Customer Satisfaction                                               

24×7 availability – we are always there when you need us                                               

200+ Fortune 500 Companies trust Arizton’s report                                               

80% of our reports are exclusive and first in the industry                                               

100% more data and analysis                                               

1500+ reports published till date                             

                  

Post-Purchase Benefit                                           

  • 1hr of free analyst discussion                                           
  • 10% off on customization                        

                 

About Us:                                                                                    

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                                                                  

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                                                                   

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.                                                                                         

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1-312-235-2040/+1 302 469 0707 
Country: United States
Website: https://www.arizton.com/market-reports/uae-construction-equipment-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The UAE Construction Equipment Market Sales is Set to Hit 28.5 Thousand Units by 2029, with Revenue Soaring by $1.27 Billion in the Next 6 Years – Arizton

Grease Market Size Analysis, Opportunities, Top Manufacturers, Growth, Trends, Key Segments, and Forecast to 2029

“Browse 150 market data Tables and 100 Figures spread through 250 Pages and in-depth TOC on “Grease Market””
The global grease market is poised for significant growth, driven by increasing industrial activities and automotive demand. The market will see robust growth in Asia-Pacific and North America, with advancements in lubrication technology and a rising need for efficient machinery maintenance.

In terms of value, the grease market is estimated to grow from USD 6.2 billion in 2024 to USD 7.4 billion by 2029, at a CAGR of  3.6%. Several key factors are driving the demand for grease in the global market. Firstly, the expanding industrial sector, particularly in emerging economies, is driving significant demand for grease as it is essential for the lubrication of machinery and equipment across various industries such as manufacturing, construction, mining, and agriculture. Additionally, the rapid growth of the automotive industry, especially in regions like Asia-Pacific, is fueling the demand for grease for lubricating components like wheel bearings, chassis, and gears.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=88373349 

Based on base oil, the grease market is segmented as mineral oil, synthetic oil and bio-based oil. Mineral oil continues to maintain its dominant position as the largest segment in the grease market, propelled by its wide availability, cost-effectiveness, and versatile performance attributes. The enduring prevalence of mineral oil in the grease market is driven by ongoing advancements in refining techniques, which continually enhance its quality and efficacy. Despite the emergence of synthetic and bio-based alternatives, the established infrastructure, cost advantages, and established performance track record of mineral oil underscore its enduring significance in the global grease market.

Based on thickener type, the grease industry is segmented as metallic soap thickener, non-soap thickener, inorganic thickener, and others. Metallic soap thickener dominated the overall grease market in terms of value, in 2023. With the increasing complexity and demands of modern machinery, there is a growing need for greases that can withstand extreme pressures and temperatures while providing long-lasting protection against wear and corrosion. Metallic soap thickeners excel in meeting these requirements, driving their popularity and adoption in the global grease market. As industries continue to prioritize efficiency, durability, and performance, the demand for metallic soap thickeners is expected to remain robust, fueling ongoing innovation and advancements in grease technology.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=88373349 

Based on end-use industry, the grease market is segmented as automotive, construction, general manufacturing, metal production, mining, power generation, agriculture and others. The automotive industry stands as the largest consumer of grease globally, relying heavily on this lubricant for the smooth operation and longevity of critical components. With the ever-expanding global fleet of vehicles and the continuous evolution of automotive technology, the demand for high-quality grease remains consistently high. As, automotive manufacturers and service providers prioritize efficiency and reliability, the importance of grease in maintaining vehicle performance underscores its status as a cornerstone of automotive maintenance and safety.

Based on region, Asia Pacific is the largest market for grease, in terms of both value and volume, in 2023. The demand for grease in Asia is significantly driven by the thriving automotive industry, fueled by the region’s burgeoning population and rapid economic growth. With Asia emerging as a major manufacturing hub for vehicles, including cars, trucks, motorcycles, and other transportation equipment, the need for grease for lubricating critical components such as wheel bearings, chassis, and engine parts is escalating. Moreover, the increasing urbanization and infrastructure development across Asia necessitate the use of heavy machinery and construction equipment, further propelling the demand for grease in industrial applications. As countries in Asia continue to modernize and expand their transportation and infrastructure networks, the demand for grease is expected to remain robust, driven by the sustained growth in the automotive and industrial sectors. 

The key players profiled in the report include ExxonMobil Corporation (US), TotalEnergies SE (France), Shell Plc. (UK), Chevron Corporation (US), BP p.l.c. (UK) Fuchs Petrolub SE (Germany), Valvoline Inc. (US), China Petroleum & Chemical Corporation (China) among others. These companies have reliable manufacturing facilities as well as strong distribution networks across key regions, such as North America, Europe, Asia Pacific, and the Middle East & Africa. They have an established portfolio of reputable products and services, a robust market presence, and strong business strategies.

Inquire Now: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=88373349 

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/grease-market-88373349.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Grease Market Size Analysis, Opportunities, Top Manufacturers, Growth, Trends, Key Segments, and Forecast to 2029

In-flight Internet Market worth $2.1 Billion by 2029, at a CAGR of 5.7%

“In-flight Internet Market”
The global In-flight Internet Market in terms of revenue was estimated to be worth $1.6 billion in 2024 and is poised to reach $2.1 billion by 2029, growing at a CAGR of 5.7% during the forecast period.

The report “In-flight Internet Market by Technology (Air-2-Ground, Satellite, Hybrid), End User (Commercial Aviation and Business Aviation), Service Model (Free, Paid, Freemium), Connectivity Speed and Regions – Global Forecast to 2029” The In-flight Internet market is estimated to be USD 1.6 billion in 2024 and is projected to reach USD 2.1 billion by 2029, at a CAGR of 5.7% from 2024 to 2029.

Improvements in satellite technology, such as the development of high-throughput satellites (HTS) and the deployment of Low Earth orbit (LEO) satellites, have significantly enhanced the capacity, speed, and reliability of in-flight Wi-Fi services. Innovations in antenna and onboard Wi-Fi systems have also contributed to better service quality and coverage.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209018219

Browse 222 market data Tables and 54 Figures spread through 217 Pages and in-depth TOC on “In-flight Internet Market “

View detailed Table of Content here – https://www.marketsandmarkets.com/Market-Reports/in-flight-internet-market-209018219.html

In-flight Internet Market

By Technology, the Hybrid- Based segment is projected to grow at the highest CAGR during the forecast period.

Hybrid systems leverage both ATG and satellite networks, providing more comprehensive coverage than either technology alone. ATG networks offer robust coverage over land, while satellites ensure connectivity over oceans and remote areas. This combination ensures continuous internet access across diverse flight routes. By dynamically switching between ATG and satellite networks based on signal strength, availability, and congestion, hybrid systems optimize connectivity performance. This ensures passengers experience consistent, high-speed internet without interruptions, regardless of their flight path.

By service model, the Free wifi segment is projected to grow at the highest CAGR during the forecast period.

Free Wi-Fi significantly enhances the passenger experience, making flights more enjoyable and productive. This can increase customer satisfaction and loyalty, encouraging repeat business and positive word-of-mouth recommendations. In a highly competitive aviation market, airlines are constantly seeking ways to differentiate themselves. Providing free Wi-Fi can be a compelling selling point, attracting passengers who prioritize connectivity when choosing an airline.

By end user, Commercial Aviation is projected to grow at the highest growth rate during the forecast period.

Passengers in commercial aviation, including both leisure and business travelers, increasingly expect reliable internet connectivity. This growing expectation is driving airlines to invest in and expand their in-flight Wi-Fi offerings. In-flight Wi-Fi represents a significant ancillary revenue stream for commercial airlines. Airlines can monetize connectivity through various models, such as tiered pricing, subscription services, and advertising. This potential for additional revenue incentivizes airlines to invest in Wi-Fi infrastructure.

North America holds the highest growth rate in the region for the In-flight Internet market.

North America, particularly the United States, has some of the busiest air travel routes and airports in the world, creating substantial demand for in-flight services, including Wi-Fi. Passengers in this region, driven by the prevalent use of digital devices and a strong desire to stay connected, have high expectations for in-flight connectivity. Airlines respond by offering robust options to meet these expectations. Additionally, the significant volume of business travel in North America, where reliable and high-speed internet is essential for productivity, further drives the demand for advanced in-flight services.

Viasat, Inc. (US), Gogo Business Aviation LLC (US), Panasonic Avionics Corporation (US), Thales (France), and Collins Aerospace (US) these key players offer connectivity applicable to various sectors and have well-equipped and robust distribution networks across North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103
City: Delray Beach
State: FL 33445
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/in-flight-internet-market-209018219.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: In-flight Internet Market worth $2.1 Billion by 2029, at a CAGR of 5.7%

Dozier Law Firm, LLC Welcomes Esteemed Attorney Jon Christopher Wolfe

MACON, GA – Dozier Law Firm, LLC, a leading plaintiff’s personal injury firm with offices in Macon, Atlanta, Savannah, and Albany, is pleased to announce that Jon Christopher “Chris” Wolfe has joined the firm as a senior attorney.

Mr. Wolfe brings a wealth of experience in civil litigation to Dozier Law Firm. With a career spanning three decades, he has established himself as a formidable presence in the Georgia legal community, particularly in the area of civil litigation defense.

“We are thrilled to welcome Chris to our team,” said David Dozier, Managing Partner at Dozier Law Firm, LLC. “His extensive experience and proven track record in civil litigation will be invaluable as we continue to advocate for our clients across Georgia.”

A graduate of Mercer University Walter F. George School of Law, Mr. Wolfe was admitted to the Georgia Bar in 1993. Throughout his career, he has earned numerous accolades, including being selected to Super Lawyers for three consecutive years from 2023 to 2025. This prestigious peer designation is awarded only to a select number of accomplished attorneys in each state, recognizing them for their professional achievement and peer recognition.

Mr. Wolfe’s transition to Dozier Law Firm, LLC marks an exciting new chapter in his career as he shifts his focus from insurance defense to plaintiff’s personal injury cases. His unique perspective and comprehensive understanding of both sides of civil litigation will undoubtedly benefit the firm’s clients.

“I’m excited to join the exceptional team at Dozier Law Firm,” said Mr. Wolfe. “I look forward to using my experience in civil litigation to help injured individuals and families across Georgia receive the justice and compensation they deserve.”

With the addition of Mr. Wolfe, Dozier Law Firm, LLC further solidifies its position as a premier personal injury firm in Georgia, continuing its commitment to providing top-tier legal representation to clients throughout the state.

For more information about Dozier Law Firm, LLC and its services, please visit dozierlaw.com or contact them at 844-436-9437.

About Dozier Law Firm, LLC

Dozier Law Firm, LLC is a leading plaintiff’s personal injury firm with offices in Macon, Atlanta, Savannah, and Albany, Georgia. The firm is dedicated to providing exceptional legal representation to individuals and families affected by personal injury, helping them secure the compensation and justice they deserve.

Media Contact
Company Name: Dozier Law Firm
Contact Person: Kevin Bryant
Email: Send Email
Phone: 478-742-8441
Address:487 Cherry Street
City: Macon
State: Georgia
Country: United States
Website: https://dozierlaw.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Dozier Law Firm, LLC Welcomes Esteemed Attorney Jon Christopher Wolfe

The Stair Lifts Market is Projected to Hit Revenue of Over $3 Billion by 2029, Highlighting Key Vendors and Innovations to Boom Your Businesses – Arizton

“Stair Lifts Market Research Report by Arizton”

   

According to Arizton’s latest research report, the global stair lifts market is growing at a CAGR of 8.9% during 2023-2029.  

 

Looking for More Information? Click: https://www.arizton.com/market-reports/global-stair-lift-market-report-2025

 

Report Scope:    

Market Size (2029): $3.60 Billion        

Market Size (2023): $2.15 Billion        

CAGR (2023-2029): 8.90%         

Historic Year:  2020-2022            

Base Year: 2023            

Forecast Year: 2024-2029            

Market Segmentation: Installation, Rail Orientation, User Orientation, Application, Distribution Channel, and Geography

Geographical Analysis: North America, Europe, APAC, Latin America, and Middle East & Africa    

    

Book the Free Sample Now: https://www.arizton.com/market-reports/global-stair-lift-market-report-2025

 

The demand for smart stair lifts is rapidly increasing worldwide, with vendors focusing on advanced features like remote control operation and voice commands.

Among global regions, the APAC region is experiencing the most significant growth in the stair lifts market, with China and South Korea emerging as the fastest-growing countries within this region.

Government regulations and initiatives emphasizing the importance of stair lifts for improving accessibility are driving market demand. Many countries are launching programs to raise awareness and promote the acceptance of stair lifts, further enhancing accessibility for individuals in need.

According to Arizton, the global stair lifts market report highlights the presence of 37 key vendors, reflecting a highly concentrated and competitive landscape. This sector is characterized by intense competition among both local and international players. The rapid pace of technological advancements poses a challenge as customers continually demand innovative and upgraded stair lift solutions. To attract new consumers, manufacturers are increasingly offering free installation services and focusing on expanding their market reach through an extensive network of dealers and distributors. Many companies are also leveraging online platforms to broaden their consumer base. Prominent vendors in the global stair lifts market include Acorn Stairlifts, Ameriglide, Bruno Independent Living Aids, Harmar, HIDRAL, Otolift, Savaria, Stannah, ThyssenKrupp, and Vimec.

 

Key Development

In 2023, Handicare Group expanded its portfolio with the introduction of the Curved Stairlifts 4000, a twin-rail curved lift. This innovative system is custom-built to complement individual staircases perfectly. The 4000 model offers a range of automatic features tailored to specific needs, including a folding hinge to prevent obstruction of nearby doorways, a powered swivel, and a footrest for effortless use. Additionally, the rail color can be fully customized to match the customer’s home decor, and the seat can be personalized with a variety of colors in three distinct styles, the Style, the Smart, and the Simplicity. This ensures a seamless integration with any home environment.

 

Key Vendors

  • Acorn Stairlifts Inc.
  • Ameriglide, Inc.
  • Bruno Independent Living Aids, Inc.
  • Harmar
  • HIDRAL, S.A.
  • Otolift
  • Savaria
  • Stannah
  • ThyssenKrupp AG
  • Vimec s.r.l.
  • Bespoke Stairlifts Limited
  • Brooks Stairlifts
  • Cibes Lift
  • DAIDO KOGYO Co., LTD.
  • Electra Group
  • Extrema S.r.l.
  • Faboc Due srl
  • Halton Stairlifts
  • HAWLE Treppenlifte
  • HIRO LIFT
  • Hogg Liftsysteme AG
  • Lehner Lifttechnik GmbH
  • Les Escalateurs Atlas
  • Liftavator, Inc.
  • Lobsang
  • Meditek
  • Millepiani Elevators
  • MPR Lifts
  • Platinum Stairlifts
  • Precision Stairlifts
  • Prism Healthcare
  • Qingdao Sinofirst Machinery Co.,Ltd
  • SECOM
  • SUGIYASU Co., Ltd
  • SUZHOU FUJILF Elevator Co., Ltd.
  • Symax Lift
  • Tai Hee Engineering Trading Pte Ltd

 

Indoor Stair Lifts Market to Dominate the Market Share with Over $3 Billion by 2029

Indoor stair lifts are the most prevalent type of stair lifts designed for installation within buildings and homes. They are specifically intended to assist individuals with mobility challenges in navigating stairs within their residences, public spaces, or healthcare facilities. Available in various configurations, including curved and straight rail options, indoor stair lifts are particularly beneficial for people with arthritis. Notably, osteoarthritis (OA), the most common form of arthritis, affects approximately 7% of the global population.

In commercial settings, indoor stair lifts have become essential in medical facilities and corporate workplaces where accessibility is a concern. These lifts help individuals with disabilities, knee pain, or injuries move more efficiently and safely upstairs, thereby facilitating their daily activities.

For homes where stairs pose a safety risk, indoor stair lifts offer an ideal solution. Their slimline designs minimize obstruction on stairways, allowing users to fold the lift when not in use, ensuring unobstructed access to the staircase. This functionality helps individuals regain confidence and independence, enabling them to perform everyday tasks more easily.

Several companies, including Bruno Independent Living Aids, Inc., Harmar, Stannah, Extrema S.r.l., HIRO LIFT, and Precision Stairlifts, offer a range of indoor stair lift options in the market.

 

Online Segment Leads Growth in Global Stair Lifts Market

The online segment is experiencing the highest growth rate in the global stair lifts market among distribution channels. This segment encompasses major online retailers, manufacturers’ websites, and e-commerce platforms. The online shopping experience offers numerous advantages, such as convenience, competitive pricing, and a broader selection of products. Customers can purchase stair lifts from the comfort of their homes, avoiding the need to visit physical stores. Online retailers often provide lower prices compared to offline stores and include delivery options, further enhancing convenience for customers.

 

Segmentation & Forecast

Installation

  • Indoor
  • Outdoor

Rail Orientation

  • Straight
  • Curved

User Orientation

  • Seated
  • Standing
  • Wheelchair Integrated Platform

Application

  • Residential
  • Healthcare
  • Leisure & Entertainment
  • Others

Distribution Channel

  • Offline
  • Online

Geography

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • The U.K.
  • France
  • Italy
  • Spain
  • APAC
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Turkey
  • South Africa
  • Saudi Arabia

 

In a nutshell, the Arizton Advisory & Intelligence market research report provides valuable market insights for industry stakeholders, investors, researchers, consultants, and business strategists aiming to gain a thorough understanding of the stair lifts market. Request for Free Sample to get a glance of the report now: https://www.arizton.com/market-reports/global-stair-lift-market-report-2025

   

What Key Findings Will Our Research Analysis Reveal?  

How big is the global stair lifts market?

What is the growth rate of the global stair lifts market?

Which region shows the highest growth in the global stair lifts market?

What are the key drivers of the global stair lifts market?

Who are the major players in the global stair lifts market?

  

Looking for Customization According to Your Business Requirement? https://www.arizton.com/customize-report/4476

Other Related Reports that Might be of Your Business Requirement  

Electric Personal Mobility Devices Market – Global Outlook & Forecast 2024-2029

The global electric personal mobility devices market to reach USD 14.85 billion by 2029, growing at a CAGR of 6.56% during the forecast period. Explore! https://www.arizton.com/market-reports/electric-peronal-mobility-devices-market

Prefabricated Interior Staircase Market – Global Outlook & Forecast 2024-2029

The global prefabricated interior staircase market to reach USD 2.04 billion by 2029, growing at a CAGR of 4.74% during the forecast period. Explore! https://www.arizton.com/market-reports/prefabricated-interior-staircase-market

  

Why Arizton?                                             

100% Customer Satisfaction                                             

24×7 availability – we are always there when you need us                                             

200+ Fortune 500 Companies trust Arizton’s report                                             

80% of our reports are exclusive and first in the industry                                             

100% more data and analysis                                             

1500+ reports published till date                           

                

Post-Purchase Benefit                                         

  • 1hr of free analyst discussion                                         
  • 10% off on customization                      

               

About Us:                                                                                  

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                                                                

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                                                                 

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.                                                                                       

 

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1-312-235-2040/+1 302 469 0707    
Country: United States
Website: https://www.arizton.com/market-reports/global-stair-lift-market-report-2025

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Stair Lifts Market is Projected to Hit Revenue of Over $3 Billion by 2029, Highlighting Key Vendors and Innovations to Boom Your Businesses – Arizton

Needle Holder Market: USD 367.3M in 2024 to USD 530.3M by 2029, CAGR 7.6%

“Major players in Needle holder market include B. Braun Melsungen Ag (Germany), Olympus Corporation (Japan), Karl Storz (Germany), Teleflex Incorporated (US), Integra LifeSciences Holdings Corporation (US), and Stille AB (Sweden).”
Browse 280 market data Tables and 40 Figures spread through 250 Pages and in-depth TOC on “Needle Holder Market by Type (Mayo-Hegar, Olsen-Hegar, Crilewood, Derf, Castroviejo), Application (Surgery, Microsurgery, Dental), Material (Stainless Steel, Tungsten Carbide), Usage Type (Reusable, Single Use), End User, Region – Global Forecast to 2029

The global needle holder market is forecasted to grow from USD 367.3 million in 2024 to USD 530.3 million by 2029, reflecting a CAGR of 7.6%. This growth is driven by increased investments in healthcare, a rise in surgeries including microsurgeries and cosmetic procedures, and the expansion of outpatient surgeries. Key players in this market include B. Braun Melsungen AG, Olympus Corporation, Karl Storz, Teleflex Incorporated, Integra LifeSciences Holdings Corporation, and Stille AB. Major trends include the dominance of reusable needle holders, with a particular growth in the Mayo-Hegar segment and a shift towards microsurgeries. Challenges such as the high cost of surgeries and the rise of non-surgical techniques like robotic-assisted surgeries could impact market expansion. North America is expected to lead the market due to its advanced healthcare infrastructure and high surgery volumes.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=260494054

Market Segmentation by Type

The needle holder market is categorized into several types: Castroviejo, Olsen-Hegar, Mayo-Hegar, Derf, Crile-Wood, and others. As of 2023, the Mayo-Hegar Needle Holder holds the largest market share due to its widespread use in various surgeries such as general, cardiovascular, and orthopedic. The Castroviejo Needle Holder is experiencing the highest growth rate due to the increasing demand for microsurgeries.

Market Segmentation by Application

The needle holder market is segmented by application into surgery, microsurgery, and dental procedures. The surgery segment held the largest market share in 2023, driven by the rising number of chronic disease patients and surgeries, particularly among individuals over 60 years old. Microsurgery is also growing as there is a shift towards more advanced surgical techniques.

Market Segmentation by End User

The needle holder market is divided into hospitals & ambulatory surgery centers (ASCs) and other end users. In 2023, hospitals & ASCs held the largest market share. This is attributed to the high volume of outpatient surgeries performed in ASCs, which offer convenience, quicker recovery, and lower costs for patients. The growth of hospitals and ASCs is expected to further drive market demand for needle holders.

Regional Market Analysis

Regionally, the needle holder market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC. North America dominated the market in 2023 due to significant government investments in healthcare, new hospital construction, and favorable healthcare reforms. The Asia Pacific region is projected to experience the highest CAGR, driven by a large patient population over 60 years old, who are more susceptible to chronic diseases.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=260494054

Market Dynamics and Key Players

The needle holder market is concentrated, with a few major players dominating the space. Key companies include B. Braun Melsungen AG (Germany), Olympus Corporation (Japan), Karl Storz (Germany), Teleflex Incorporated (US), Integra LifeSciences Holdings Corporation (US), and Stille AB (Sweden).

B. Braun Melsungen AG

In 2023, B. Braun Melsungen AG led the needle holder market. The company maintains its top position through extensive distribution networks across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. B. Braun is a major manufacturer of surgical and microsurgical instruments, including needle holders used in a variety of surgeries such as cardiac, plastic, and orthopedic, contributing to its significant market share.

Olympus Corporation

Olympus Corporation held the second position in the needle holder market in 2023. Known for its trusted brand in the medical device industry, Olympus continues to invest heavily in research and development (R&D), increasing its R&D spending to USD 447 million in 2023 from USD 442 million in 2022. This investment supports Olympus in maintaining its competitive edge and enhancing its product offerings.

Teleflex Incorporated

Teleflex Incorporated ranked third in the needle holder market in 2023. The company offers a range of needle holders used in various surgical procedures and focuses on expanding its global reach. Operating in over 150 countries, Teleflex’s strategic expansion efforts help reduce its reliance on any single market, broadening its market presence and strengthening its product portfolio.

For more information, Inquire Now!

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.prnewswire.com/news-releases/needle-holder-market-usd-367-3m-in-2024-to-usd-530-3m-by-2029–cagr-7-6–marketsandmarkets-302247478.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Needle Holder Market: USD 367.3M in 2024 to USD 530.3M by 2029, CAGR 7.6%

Autoimmune Hepatitis Treatment Market Size is expected to increase by 2034, estimates DelveInsight

Autoimmune Hepatitis Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for Autoimmune Hepatitis Therapeutics includes promising candidates that aim to not only treat acute attacks but also prevent recurrence.

 

DelveInsight’s “Autoimmune Hepatitis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Autoimmune Hepatitis, historical and forecasted epidemiology as well as the Autoimmune Hepatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Unlock detailed insights into the Autoimmune Hepatitis Market by downloading the comprehensive report from DelveInsight @ Autoimmune Hepatitis Therapeutics Market

 

Key Takeaways from the Autoimmune Hepatitis Market Report

  • In August 2024:- Novartis Pharmaceuticals- Patients will be randomly assigned to different doses of VAY736 or placebo. The primary analysis is planned at 24 weeks. A subsequent study part will then test the efficacy and safety of VAY736 in a parallel group design. For this part of the trial a new group of autoimmune hepatitis patients will be enrolled.
  • In August 2024:- Kezar Life Sciences, Inc.- This is a Phase 2a, multi-center, placebo-controlled study in which patients with autoimmune hepatitis will receive zetomipzomib or placebo in addition to standard-of-care for 24 weeks; an optional open-label extension period allows patients to receive zetomipzomib (KZR-616) for an additional 24 weeks of treatment.
  • According to the American Liver Foundation, Autoimmune Hepatitis (AIH) is a disease in which the body’s immune system attacks the liver and causes it to become inflamed. The disease is chronic, meaning it lasts many years. If untreated, it can lead to cirrhosis and liver failure.
  • It was found that the prevalence of AIH in the US is approximately 31.2 per 100,000 individuals.
  • The leading Autoimmune Hepatitis Companies such as Abbott Laboratories, AbbVie, Inc., Arihantanam Life Care Pvt Ltd., AstraZeneca PLC, Bayer AG, Biocon, Ltd., Bio-Rad Laboratories, Inc., Bristol-Myers Squibb Co., Cipla, Ltd., GlaxoSmithKline PLC, Gilead Life sciences, Inc., Johnson & Johnson Services, Inc., Inova Diagnostics, Inc., Merck & Co., Inc., Novartis International AG, Organovo Holdings, Inc., Pfizer, Inc., Upcyte Technologies GmbH, and others.
  • Promising Autoimmune Hepatitis Therapies such as VAY736, HR19042 Capsules, zetomipzomib, and others.

 

Gain a competitive edge in the Autoimmune Hepatitis Market by exploring our in-depth analysis. Visit our website to access the full report and make informed strategic decisions @ Autoimmune Hepatitis Treatment Drugs

 

Autoimmune Hepatitis Epidemiology Segmentation in the 7MM

  • Total Autoimmune Hepatitis Prevalent Cases
  • Autoimmune Hepatitis Gender-specific Diagnosed Prevalent Cases
  • Autoimmune Hepatitis Type-specific Diagnosed Prevalent Cases
  • Total Autoimmune Hepatitis Diagnosed Prevalent Cases
  • Autoimmune Hepatitis Age-specific Diagnosed Prevalent Cases
  • Autoimmune Hepatitis Treated Cases

 

Autoimmune Hepatitis Market Insights

The goal of treatment of AIH is to stop the body’s attack on itself by suppressing the immune system. The basic treatment is the administration of immunosuppressive drugs, the first of which is the oral drug corticosteroid. Medications help to regulate an overactive immune system. Both type 1 and type 2 autoimmune hepatitis are commonly treated with daily doses of the steroid prednisone. Initially, a high dose may be prescribed, which will be gradually reduced as the disease is controlled. The aim is to determine the lowest effective dose that manages the condition.

 

Discover key developments and opportunities in the Autoimmune Hepatitis Market. Click here to learn more from DelveInsight’s latest report @ Autoimmune Hepatitis Market Size

 

Autoimmune Hepatitis Treatment Market Landscape

The Autoimmune Hepatitis treatment market is shifting towards personalized and precision medicine. Efforts are focused on understanding the underlying disease mechanisms to tailor therapies more effectively to individual patients. This includes exploring genetic and molecular profiles to guide treatment decisions and improve outcomes. The emphasis is increasingly on integrating innovative research findings to address the limitations of current treatments and enhance patient care.

 

Autoimmune Hepatitis Emerging Drugs Profile

  • Zetomipzomib (KZR-616): Kezar Life Sciences
  • Ianalumab (VAY736): Novartis/MorphoSys

 

Download DelveInsight’s Autoimmune Hepatitis Market report today and stay ahead in this rapidly evolving field. @ Autoimmune Hepatitis Clinical Trials

 

Scope of the Autoimmune Hepatitis Market Report

  • Coverage- 7MM
  • Autoimmune Hepatitis Companies- Abbott Laboratories, AbbVie, Inc., Arihantanam Life Care Pvt Ltd., AstraZeneca PLC, Bayer AG, Biocon, Ltd., Bio-Rad Laboratories, Inc., Bristol-Myers Squibb Co., Cipla, Ltd., GlaxoSmithKline PLC, Gilead Life sciences, Inc., Johnson & Johnson Services, Inc., Inova Diagnostics, Inc., Merck & Co., Inc., Novartis International AG, Organovo Holdings, Inc., Pfizer, Inc., Upcyte Technologies GmbH, and others.
  • Autoimmune Hepatitis Therapies- VAY736, HR19042 Capsules, zetomipzomib, and others.
  • Autoimmune Hepatitis Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
  • Autoimmune Hepatitis Unmet Needs, KOL’s views, Analyst’s views, Autoimmune Hepatitis Market Access and Reimbursement

 

Download the report to understand which factors are driving Autoimmune Hepatitis Market Trends @ Autoimmune Hepatitis Market Trends

 

Table of Content

1. Key Insights

2. Executive Summary of Autoimmune Hepatitis

3. Competitive Intelligence Analysis for Autoimmune Hepatitis

4. Autoimmune Hepatitis: Market Overview at a Glance

5. Autoimmune Hepatitis: Disease Background and Overview

6. Patient Journey

7. Autoimmune Hepatitis Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Autoimmune Hepatitis Unmet Needs

10. Key Endpoints of Autoimmune Hepatitis Treatment

11. Autoimmune Hepatitis Marketed Products

12. Autoimmune Hepatitis Emerging Therapies

13. Autoimmune Hepatitis: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Autoimmune Hepatitis

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Autoimmune Hepatitis Treatment Market Size is expected to increase by 2034, estimates DelveInsight

Asthma Treatment Market Size in the 7MM was ~USD 19,000 million in 2023, estimated DelveInsight

Asthma Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for Asthma Therapeutics includes promising candidates that aim to not only treat acute attacks but also prevent recurrence.

 

DelveInsight’s “Asthma Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding of the Asthma, historical and forecasted epidemiology as well as the Asthma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

 

Unlock detailed insights into the Asthma Market by downloading the comprehensive report from DelveInsight @ Asthma Market

 

Key Takeaways from the Asthma Market Report

  • In September 2024:- AstraZeneca- A Randomised, Double-blind, Parallel Group, Placebo Controlled, 4-Week, Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With Asthma. The purpose of this study is to investigate the effect on airway inflammation and JAK1-associated signalling pathways of AZD4604 compared with placebo in participants with moderate-to-severe asthma.
  • In September 2024:- Chiesi Farmaceutici S.p.A.- The purpose of this study is to evaluate the efficacy and safety of CHF6001 (Tanimilast) as add-on to maintenance of inhaled corticosteroids in combination with Long-acting ß2-agonists in the target patient population. (TANGO)
  • As per DelveInsight analysis, there were approximately 55 million diagnosed prevalent cases of asthma, in the 7MM, in 2023. These cases are projected to increase during the forecast period (2024-2034).
  • Among the 7MM, the US accounted for the highest, approximately 47% of the total diagnosed prevalent cases in 2023, while Spain accounted for the least with nearly 5% of the total.
  • According to DelveInsight analysis, there were around 4.8 million pediatrics and 21.2 million adults cases of asthma in the US in 2023, with numbers expected to rise by 2034.
  • The leading Asthma Companies such as Cipla Ltd, Hamad Medical Corporation, Areteia Therapeutics, AstraZeneca, Amgen, GSK, Sanofi, TEVA Pharmaceutical, Regeneron Pharmaceuticals, Shanghai Hengrui Pharmaceutical Co., Ltd., Novartis Pharmaceuticals, and others.
  • Promising Asthma Therapies such as Dexpramipexole Dihydrochloride, Benralizumab, Dupilumab, Rocatinlimab, Mepolizumab, Tezepelumab, GSK3511294 (Depemokimab), and others.

 

Gain a competitive edge in the Asthma Market by exploring our in-depth analysis. Visit our website to access the full report and make informed strategic decisions @ Asthma Treatment Drugs

 

Asthma Epidemiology Segmentation in the 7MM

  • Total Diagnosed Prevalent Cases
  • Age-specific Cases
  • Gender-specific Cases
  • Severity-specific Cases
  • Type-specific Severity Cases

 

Asthma Treatment Market

The mainstay treatment for persistent asthma consists of inhaled corticosteroids. Quick-relief (reliever) or rescue medicines quickly ease symptoms that arise acutely. Short-acting beta-agonists (SABAs) rapidly reduce airway bronchoconstriction and are recommended rescue medication for rapid symptom relief. Additional long-term controller medicines, such as long-acting beta 2 agonists (LABA), montelukast, or theophylline, are added if asthma is still uncontrolled.

 

Discover key developments and opportunities in the Asthma Market. Click here to learn more from DelveInsight’s latest report @ Asthma Market Size

 

Asthma Marketed Drugs

 

  • TEZSPIRE (tezepelumab-ekko): Amgen/AstraZeneca

TEZSPIRE (tezepelumab) was developed by AstraZeneca in collaboration with Amgen as a first-in-class human monoclonal antibody that inhibits the action of TSLP, a key epithelial cytokine that sits at the top of multiple inflammatory cascades and is critical in the initiation and persistence of allergic, eosinophilic and other types of airway inflammation associated with severe Asthma, including airway hyperresponsivenes. It is approved in the US, EU, Japan, and other countries for treating severe Asthma.

 

  • CINQAIR (reslizumab): Teva Pharmaceutical

Reslizumab injection is a humanized interleukin-5 antagonist monoclonal antibody for add-on maintenance treatment of adult patients with severe Asthma and an eosinophilic phenotype developed by Teva Pharmaceuticals. CINQAIR is indicated for the add-on maintenance treatment of patients with severe Asthma aged 18 and older with an eosinophilic phenotype. It is approved in the US, EU, but not in Japan.

  • FASENRA (benralizumab): AstraZeneca

FASENRA (benralizumab) is a monoclonal antibody that binds directly to the IL-5 receptor alpha on eosinophils and attracts natural killer cells to induce rapid and near-complete depletion of eosinophils via apoptosis (programmed cell death). FASENRA is AstraZeneca’s first respiratory biologic, approved as an add-on maintenance treatment in severe eosinophilic Asthma in the US, EU, Japan, and other countries, with further regulatory reviews ongoing.

 

Asthma Emerging Drugs

 

  • GSK3511294 (Depemokimab): GlaxoSmithKline

GSK is developing GSK3511294 (depemokimab), a humanized anti-interleukin (IL)-5 monoclonal antibody, to treat severe eosinophilic Asthma. As a new biological entity, it is engineered to ensure high affinity and long-acting suppression of IL-5 functions. IL-5 is cytokines responsible for the proliferation, activation, and survival of eosinophils, thus making them a proven treatment target for severe Asthma patients with higher levels of eosinophils. Depemokimab, with an extended half-life and improved IL-5 affinity compared to other approved therapies, is the first biologic to be administered subcutaneously once every 26 weeks.

 

  • PT010: AstraZeneca

PT010, being developed by AstraZeneca, is a fixed-dose combination of micronized budesonide, an inhaled corticosteroid (ICS), micronized glycopyrrolate (an anticholinergic), and micronized formoterol fumarate, a LABA, for oral inhalation administered via a pressurized metered-dose inhaler (pMDI) using Aerosphere delivery technology. AstraZeneca is conducting multiple Phase III trials to assess the safety and efficacy of PT010 in adults and adolescents with severe Asthma inadequately controlled with the standard of care.

 

Asthma Market Outlook

The goal of treatment is to minimize symptom burden (i.e., maintain normal activity levels while maintaining good symptom control) and reduce the possibility of adverse events such as fixed airflow limitation, exacerbations, and therapeutic side effects. Guidelines-based Asthma management emphasizes the severity of the condition and selecting the best medical treatment to manage symptoms and lower the likelihood of exacerbations.

 

Download DelveInsight’s Asthma Market report today and stay ahead in this rapidly evolving field. @ Asthma Clinical Trials

 

Scope of the Asthma Market Report

  • Coverage- 7MM
  • Asthma Companies- Cipla Ltd, Hamad Medical Corporation, Areteia Therapeutics, AstraZeneca, Amgen, GSK, Sanofi, TEVA Pharmaceutical, Regeneron Pharmaceuticals, Shanghai Hengrui Pharmaceutical Co., Ltd., Novartis Pharmaceuticals, and others.
  • Asthma Therapies- Dexpramipexole Dihydrochloride, Benralizumab, Dupilumab, Rocatinlimab, Mepolizumab, Tezepelumab, GSK3511294 (Depemokimab), and others.
  • Asthma Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
  • Asthma Unmet Needs, KOL’s views, Analyst’s views, Asthma Market Access and Reimbursement

 

Download the report to understand which factors are driving Asthma Market Trends @ Asthma Market Trends

 

Table of Content

1 Key Insights

2 Report Introduction

3 Asthma Market Overview at a Glance

4 Methodology of Asthma Epidemiology and Market

5 Executive Summary of Asthma

6 Key Events

7 Disease Background and Overview

8 Epidemiology and Patient Population

9 Patient Journey

10 Marketed Therapies

11 Emerging Therapies

12 Asthma: Market Analysis

13 KOL Views

14 SWOT Analysis

15 Unmet needs

16 Market Access and Reimbursement

17 Appendix

18 DelveInsight Capabilities

19 Disclaimer

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Asthma Treatment Market Size in the 7MM was ~USD 19,000 million in 2023, estimated DelveInsight

Cardiac Tissue Engineering Market to Reach USD 1,333.6 M by 2029, Driven by Stem Cell Research and Support

“Prominent players in the Cardiac Tissue Engineering market include, Terumo corporation (Japan), Artivion, Inc. (US), Baxter international, Inc. (US), Teijin Limited (Japan), Medtronic Plc. (Ireland), Boston Scientific Corporation (US), Abbott Laboratories (US), Merck KGaA (Germany), Elutia. (US), W. L. Gore & Associates, Inc. (US), Meril Lifesciences Pvt.Ltd (India)”
Browse 426 market data Tables and 54 Figures spread through 336 Pages and in-depth TOC on “Cardiac Tissue Engineering Market by Material (Scaffold, Stem cells), Product (Heart Valve, Vascular Grafts), Applications (MI,Congenital Heart Disease), End-User (Hospitals & Clinics, Academics & Research Institutes) – Global Forecast to 2029

The cardiac tissue engineering market is expected to grow from USD 621.2 million in 2024 to USD 1,333.6 million by 2029, reflecting a compound annual growth rate (CAGR) of 16.5%. This growth is driven by increased demand for regenerative medicine, advancements in 3D bioprinting, and rising cardiovascular disease prevalence. Key market drivers include substantial support from government and major market players, exemplified by a CAD 23.6 million fundraising campaign in Canada. However, high treatment costs pose a significant restraint, limiting access to affluent patients and well-funded healthcare systems. Opportunities for growth are bolstered by the rising demand for stem cell research, while challenges include limited awareness about cardiac tissue engineering. Major companies in the field include Terumo Corporation, Artivion, Baxter International, and Medtronic, with North America leading the market due to high healthcare spending and advanced medical infrastructure.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=264276500

Material Segmentation

The market is divided into stem cells and scaffolds, with scaffolds further categorized into biological and synthetic types. In 2023, biological scaffolds held a significant market share due to their superior biological activity, which enhances cell adhesion and growth, and their ability to seamlessly integrate with the host’s extracellular matrix. This integration minimizes adverse immune reactions and supports natural tissue regeneration. In contrast, synthetic scaffolds, including polystyrene and poly-l-lactic acid (PLLA), face challenges such as reduced bioactivity and complications with degradation processes, making biological scaffolds a preferred option for cardiac tissue engineering.

Product Segmentation

The cardiac tissue engineering market includes vascular grafts, cardiac patches, and heart valves. In 2023, cardiac patches represented a significant portion of the market due to their multifunctional therapeutic capabilities. These patches, which may be composed of scaffolds or contain therapeutic agents, provide crucial mechanical support to weakened myocardial tissue and enhance heart function by promoting synchronized electrical conduction. Their ability to deliver targeted therapies directly to the infarct zone while minimizing systemic side effects makes them a vital component in cardiac repair and regeneration, contributing to their substantial market presence.

Application Segmentation

The market is categorized into myocardial infarction, heart valve repair/replacement, congenital heart disease treatment, and other applications. In 2023, the myocardial infarction segment held the largest share due to its high global prevalence and significant mortality rate. As myocardial infarction remains a leading cause of death worldwide, there is a pressing need for advanced therapeutic solutions. Cardiac tissue engineering offers innovative methods to repair and regenerate damaged heart tissue, addressing critical clinical challenges and driving substantial investment and research in this area.

Regional Growth

The cardiac tissue engineering market is divided into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2023, Asia Pacific emerged as the fastest-growing region, driven by a rising prevalence of cardiovascular diseases, largely due to an aging population. According to the Economic and Social Commission for Asia and the Pacific (ESCAP), the region’s elderly population is expected to double by 2050, increasing the demand for advanced cardiac treatments. This demographic shift, coupled with a surge in cardiovascular conditions, is accelerating investments in research, healthcare infrastructure, and innovative therapies, solidifying Asia Pacific’s leading growth position in the market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=264276500

Key Market Players

The cardiac tissue engineering market is dominated by several major players, including Terumo Corporation (Japan), Artivion, Inc. (US), Baxter International, Inc. (US), Teijin Limited (Japan), Medtronic Plc (Ireland), Boston Scientific Corporation (US), Abbott Laboratories (US), Merck KGaA (Germany), Elutia (US), W. L. Gore & Associates, Inc. (US), Meril Lifesciences Pvt. Ltd. (India), Fujifilm Holdings Corporation (Japan), Vascudyne, Inc. (US), BICO – THE BIO CONVERGENCE COMPANY (Sweden), ReproCELL, Inc. (US), PromoCell GmbH (Germany), Axol Bioscience Ltd. (UK), BPS Bioscience, Inc. (US), Cell Application, Inc. (US), and Viscofan DE GmbH (Germany).

Terumo Corporation (Japan)

Terumo Corporation is a leading player in the cardiac tissue engineering market, recognized for its HeartSheet product derived from autologous skeletal myoblast sheets. This product is designed to treat heart failure caused by chronic ischemic disease and has gained approval under Japan’s expedited regulatory framework for regenerative medicine. Terumo’s extensive global reach, spanning over 160 countries, and its comprehensive cardiovascular division enhance its position in the industry. The company’s focus on innovative product development and global distribution underlines its leadership and capability in addressing diverse cardiac care needs.

Artivion, Inc. (US)

Artivion, Inc., previously known as CryoLife Inc., is a notable player in the cardiac tissue engineering sector, particularly recognized for its SynerGraft product. This product helps to reduce immune rejection risk while supporting natural tissue regeneration. Artivion’s strategic presence across multiple regions, including North America, Europe, the Middle East, Africa, Asia Pacific, and Latin America, ensures broad accessibility to its advanced medical devices and implantable human tissues. This extensive reach supports global adoption and reinforces Artivion’s role in advancing cardiac care solutions.

Baxter International, Inc. (US)

Baxter International Inc. stands out in the cardiac tissue engineering market for its innovative contributions to medical technology and regenerative therapies. The company’s advanced surgery segment offers Peri-Guard and Supple Peri-Guard products for cardiothoracic surgery, made from bovine pericardium. These products are noted for their exceptionally low adverse event rate of less than 0.07%. Baxter’s extensive global network, including the US, Europe, the Middle East, Africa, Latin America, Asia, Canada, Japan, Australia, and New Zealand, ensures wide availability of its high-quality cardiac solutions, reinforcing its significant role in the market.

For more information, inquire now! Inquire Now

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.prnewswire.com/news-releases/cardiac-tissue-engineering-market-to-reach-usd-1-333-6-m-by-2029–driven-by-stem-cell-research-and-support–marketsandmarkets-302241717.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Cardiac Tissue Engineering Market to Reach USD 1,333.6 M by 2029, Driven by Stem Cell Research and Support